US 7759304
Targeting complement factor H for treatment of diseases
granted A61KA61K38/00A61P
Quick answer
US patent 7759304 (Targeting complement factor H for treatment of diseases) held by The Regents of the University of Colorado expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/00, A61P, A61P1/04, A61P11/06